Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 601–615 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2086 PTEN Gene Cowden Syndrome Type 1 Genetic Test This test identifies germline mutations in the PTEN gene associated with an increased risk of developing Cowden syndrome and related cancers.	Peripheral whole blood or FTA card (dried blood spot)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PTEN gene sequence", "Copy Number Variations (CNV) in PTEN gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Individuals with multiple benign tumors", "Individuals with a strong family history of breast, thyroid, endometrial, or other PTEN-associated cancers"] Measurement technique Confirm with laboratory Codes LOINC: 33987-2 ICD-10: Q85.8 Clinical summary This test identifies germline mutations in the PTEN gene associated with an increased risk of developing Cowden syndrome and related cancers.
TEST-2974 PTH1R Gene Chondrodysplasia, Blomstrand Type Genetic Test This test evaluates the PTH1R gene for pathogenic variants associated with Blomstrand chondrodysplasia.	Peripheral blood (EDTA tube) or extracted genomic DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PTH1R gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Novel splice-site mutations"] Parameters [] Preparation [] Indications ["Individuals with clinical or radiological suspicion of skeletal dysplasia", "Individuals with a strong family history of lethal neonatal bone disorders", "Couples with a previous pregnancy affected by Blomstrand chondrodysplasia"] Measurement technique Confirm with laboratory Codes LOINC: 47619-6 ICD-10: Q77.8 Clinical summary This test evaluates the PTH1R gene for pathogenic variants associated with Blomstrand chondrodysplasia.
TEST-3600 PXDN Gene Corneal Opacification and Other Ocular Anomalies Genetic Test This genetic test analyzes the PXDN gene to detect pathogenic variants causing congenital corneal opacification and associated ocular anomalies.	Whole blood, extracted DNA, cheek swab (buccal mucosa), dried blood spots on FTA cards, ocular fluid	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PXDN gene variants", "Pathogenic mutations"] Parameters [] Preparation ["Mandatory genetic counselling session before sample collection"] Indications ["Clinical suspicion of PXDN-related disease", "Family history of corneal opacification", "Need for recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 94221-7 ICD-10: H17.8 Clinical summary This genetic test analyzes the PXDN gene to detect pathogenic variants causing congenital corneal opacification and associated ocular anomalies.
TEST-6334 PYGL Gene Glycogen Storage Disease Type VI (Hers Disease) Genetic Test This test identifies pathogenic variants in the PYGL gene, confirming a diagnosis of Glycogen Storage Disease Type VI (Hers disease).	Whole blood (3–5 mL), extracted DNA, or FTA card blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PYGL gene mutations", "Pathogenic variants (missense, nonsense, frameshift, splice-site)"] Parameters [] Preparation ["No specific fasting required for blood draw.", "Inform phlebotomist of any medications."] Indications ["Suspected Glycogen Storage Disease Type VI (Hers disease)", "Clinical signs and biochemical testing suggestive of GSD VI"] Measurement technique Confirm with laboratory Codes LOINC: 91818-9 ICD-10: E74.03 Clinical summary This test identifies pathogenic variants in the PYGL gene, confirming a diagnosis of Glycogen Storage Disease Type VI (Hers disease).
TEST-4561 RAB27A Gene Griscelli Syndrome Type 2 Genetic Test This test evaluates the entire coding region of the RAB27A gene for pathogenic variants associated with Griscelli syndrome type 2.	Whole Blood (EDTA) or Buccal Swab (DNA FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RAB27A gene", "Deletion/duplication analysis of the RAB27A gene"] Parameters [] Preparation ["No special preparation is needed", "Fasting is not required"] Indications ["Suspected diagnosis of Griscelli syndrome type 2 based on clinical presentation", "Family history of Griscelli syndrome type 2", "Carrier screening in at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 92822-5 ICD-10: E70.330 Clinical summary This test evaluates the entire coding region of the RAB27A gene for pathogenic variants associated with Griscelli syndrome type 2.
TEST-5107 RAD51 Gene Mirror Movements Type 2 Genetic Test This test evaluates the RAD51 gene for pathogenic variants associated with congenital mirror movements type 2 (CMM2) using next-generation sequencing.	Whole blood, DNA, dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RAD51 gene variants (SNVs, indels, CNVs)", "Pathogenic variants linked to CMM2"] Parameters [] Preparation ["No fasting required", "Provide complete clinical history and pedigree chart to phlebotomist"] Indications ["Diagnosis of congenital mirror movements type 2 (CMM2)", "Family history of CMM2"] Measurement technique Confirm with laboratory Codes LOINC: 81252-9 ICD-10: G25.82 Clinical summary This test evaluates the RAD51 gene for pathogenic variants associated with congenital mirror movements type 2 (CMM2) using next-generation sequencing.
TEST-4579 RAG1 Gene (Severe Combined Immunodeficiency, B‑cell Negative) Genetic Test This genetic test identifies pathogenic variants in the RAG1 gene associated with B-cell negative Severe Combined Immunodeficiency (SCID). It detects sequence variants, deletions,...	Whole Blood (EDTA), Extracted DNA (≥2 µg), or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RAG1 gene sequence variants", "RAG1 gene deletions", "RAG1 gene copy number variations (CNV)"] Parameters [] Preparation ["Complete clinical history questionnaire", "Mandatory pre-test genetic counselling session", "Do NOT stop prescribed medications without physician advice"] Indications ["Clinical suspicion of SCID", "Known family history of RAG1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81263-8 ICD-10: D81.1 Clinical summary This genetic test identifies pathogenic variants in the RAG1 gene associated with B-cell negative Severe Combined Immunodeficiency (SCID). It detects sequence variants, deletions, and copy number variations.
TEST-5311 RAG2 Gene Combined Cellular and Humoral Immune Defects with Granulomas Genetic Test This test uses Next-Generation Sequencing to analyze the entire coding region of the RAG2 gene for pathogenic variants linked to combined immunodeficiency with granulomas.	Whole Blood (EDTA tube), Extracted DNA (min 1 µg), or One Drop of Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RAG2 gene sequence", "Pathogenic variants (SNVs, indels, copy number variants)"] Parameters [] Preparation ["Provide detailed clinical history", "Mandatory genetic counselling session", "Construct comprehensive pedigree chart"] Indications ["Suspected combined cellular and humoral immune deficiency", "Family screening for RAG2-related disorders", "Research applications"] Measurement technique Confirm with laboratory Codes LOINC: 48707-5 ICD-10: D81.32 Clinical summary This test uses Next-Generation Sequencing to analyze the entire coding region of the RAG2 gene for pathogenic variants linked to combined immunodeficiency with granulomas.
TEST-2845 RAPSN Gene Fetal Akinesia Deformation Sequence Genetic Test (NGS) This test evaluates the RAPSN gene for pathogenic variants associated with fetal akinesia deformation sequence and congenital myasthenic syndrome.	Venous whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RAPSN gene", "Presence of disease-causing mutations"] Parameters [] Preparation ["Detailed clinical history required", "Pre-test genetic counselling session mandatory", "Pedigree chart of affected family members needed"] Indications ["Prenatal diagnosis of FADS", "Diagnosis of congenital myasthenic syndrome", "Family history of RAPSN-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 82919-7 ICD-10: G70.2 Clinical summary This test evaluates the RAPSN gene for pathogenic variants associated with fetal akinesia deformation sequence and congenital myasthenic syndrome.
TEST-4026 RASA1 Gene Genetic Test for Capillary Malformation-Arteriovenous Malformation This test evaluates the RASA1 gene for pathogenic variants associated with Capillary Malformation-Arteriovenous Malformation (CM-AVM) syndrome.	Whole blood (EDTA tube), extracted DNA, or FTA card blood spot	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RASA1 gene pathogenic variants", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["Detailed clinical history documentation", "Genetic counselling session", "Three-generation pedigree chart"] Indications ["Suspected Capillary Malformation-Arteriovenous Malformation (CM-AVM) syndrome", "Family history of CM-AVM", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 50398-7 ICD-10: Q27.3 Clinical summary This test evaluates the RASA1 gene for pathogenic variants associated with Capillary Malformation-Arteriovenous Malformation (CM-AVM) syndrome.
TEST-5482 RBPJ Gene Adams-Oliver Syndrome Type 3 Genetic Test This test identifies pathogenic variants in the RBPJ gene associated with Adams-Oliver syndrome type 3.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in RBPJ gene", "Copy Number Variants (CNVs) in RBPJ gene"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Suspected Adams-Oliver syndrome type 3", "Unexplained scalp defects", "Limb anomalies", "Congenital heart disease"] Measurement technique Confirm with laboratory Codes LOINC: 81306-6 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the RBPJ gene associated with Adams-Oliver syndrome type 3.
TEST-3635 RDH5 Gene Fundus Albipunctatus Genetic Test This genetic test identifies mutations in the RDH5 gene associated with Fundus Albipunctatus, an inherited retinal dystrophy.	Whole Blood, Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RDH5 gene sequence", "Pathogenic variants in RDH5"] Parameters [] Preparation [] Indications ["Suspected Fundus Albipunctatus", "Family history of retinal dystrophy"] Measurement technique Confirm with laboratory Codes LOINC: 82455-4 ICD-10: H35.59 Clinical summary This genetic test identifies mutations in the RDH5 gene associated with Fundus Albipunctatus, an inherited retinal dystrophy.
TEST-2765 RET Gene Hirschsprung Disease Genetic Test This test evaluates the RET proto-oncogene for pathogenic variants associated with Hirschsprung disease and Multiple Endocrine Neoplasia type 2.	Whole blood (EDTA or FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RET gene pathogenic variants", "Exon coverage", "Splice-site regions"] Parameters [] Preparation [] Indications ["Suspected Hirschsprung disease", "Family history of Hirschsprung disease or MEN2", "Pre-operative diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21687-8 ICD-10: Q43.1, Z15.01, Z14.8 Clinical summary This test evaluates the RET proto-oncogene for pathogenic variants associated with Hirschsprung disease and Multiple Endocrine Neoplasia type 2.
TEST-1168 Retinal Degeneration Gene Panel Test This test evaluates over 250 genes associated with inherited retinal dystrophies using Next-Generation Sequencing (NGS). It identifies genetic mutations contributing to conditions...	Peripheral whole blood	4–6 weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic mutations in 250+ genes linked to retinal dystrophies", "Analytical sensitivity"] Parameters [] Preparation ["No fasting required", "No special preparation needed"] Indications ["Suspected hereditary retinal disorder", "Confirmation of clinical diagnosis", "Prognosis determination", "Guidance for gene-specific therapies", "Clinical trial eligibility assessment"] Measurement technique Confirm with laboratory Codes LOINC: 94395-2 ICD-10: H35.5 Clinical summary This test evaluates over 250 genes associated with inherited retinal dystrophies using Next-Generation Sequencing (NGS). It identifies genetic mutations contributing to conditions like retinitis pigmentosa and Stargardt disease.
TEST-3497 RGS9BP Gene Bradyopsia Genetic Test This test detects pathogenic variants in the RGS9BP gene associated with bradyopsia, a rare cone dysfunction syndrome.	Whole Blood (EDTA), Extracted DNA, or FTA Card (dried blood spot)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RGS9BP gene", "Single nucleotide variants", "Small insertions/deletions", "Splice-site mutations"] Parameters [] Preparation ["Inform phlebotomist if taking blood-thinners.", "Genetic counselling session required before testing."] Indications ["Suspected cone dysfunction", "Distinguishing bradyopsia from other retinal disorders", "Evaluating dynamic vision in athletes", "Research purposes"] Measurement technique Confirm with laboratory Codes LOINC: 94900-7 ICD-10: H53.8 Clinical summary This test detects pathogenic variants in the RGS9BP gene associated with bradyopsia, a rare cone dysfunction syndrome.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.